SunRISe4 study
YOUR LINK HERE:
http://youtube.com/watch?v=9kvRt8qJpKs
Dr. Sarah Psutka talks about the SunRISe-4 study: TAR-200 plus cetrelimab or cetrelimab alone as neoadjuvant therapy in patients with muscle-invasive bladder...
bladder cancers, oncology, ASCO GU23
#############################
